Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.8533
-0.0298 (-3.37%)
At close: Jul 17, 2026, 4:00 PM EDT
0.8500
-0.0033 (-0.39%)
After-hours: Jul 17, 2026, 6:44 PM EDT
Oncolytics Biotech Market Cap
Oncolytics Biotech has a market cap or net worth of $101.84 million as of July 17, 2026. Its market cap has decreased by -5.70% in one year.
Market Cap
101.84M
Enterprise Value
96.86M
1-Year Change
-5.70%
Ranking
Category
Stock Price
$0.85
ChartMarket Cap Chart
Since September 30, 2002, Oncolytics Biotech's market cap has increased from $30.90M to $101.84M, an increase of 229.59%. That is a compound annual growth rate of 5.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 101.80M | 12.36% |
| Dec 31, 2025 | 90.60M | 28.69% |
| Dec 31, 2024 | 70.40M | -25.27% |
| Dec 29, 2023 | 94.20M | -0.95% |
| Dec 30, 2022 | 95.10M | 24.48% |
| Dec 31, 2021 | 76.40M | -24.21% |
| Dec 31, 2020 | 100.80M | -15.44% |
| Dec 31, 2019 | 119.20M | 341.48% |
| Dec 31, 2018 | 27.00M | -60.93% |
| Dec 29, 2017 | 69.10M | 178.63% |
| Dec 30, 2016 | 24.80M | -1.59% |
| Dec 31, 2015 | 25.20M | -43.88% |
| Dec 31, 2014 | 44.90M | -62.24% |
| Dec 31, 2013 | 118.90M | -57.43% |
| Dec 31, 2012 | 279.30M | 5.40% |
| Dec 30, 2011 | 265.00M | -35.74% |
| Dec 31, 2010 | 412.40M | 260.49% |
| Dec 31, 2009 | 114.40M | 129.72% |
| Dec 31, 2008 | 49.80M | -20.70% |
| Dec 31, 2007 | 62.80M | -17.04% |
| Dec 29, 2006 | 75.70M | -49.09% |
| Dec 30, 2005 | 148.70M | 19.06% |
| Dec 31, 2004 | 124.90M | 47.81% |
| Dec 31, 2003 | 84.50M | 194.43% |
| Dec 31, 2002 | 28.70M | -7.12% |
View and export this data all the way back to 2002. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fortress Biotech | 111.62M |
| Polaryx Therapeutics | 107.94M |
| Coya Therapeutics | 106.50M |
| Kalaris Therapeutics | 104.21M |
| PolyPid | 102.96M |
| Black Diamond Therapeutics | 102.57M |
| Aldeyra Therapeutics | 101.94M |
| ImmuCell | 100.65M |